Stay updated on Liquid Biopsy Predicts 1st-line Immunotherapy Response Clinical Trial
Sign up to get notified when there's something new on the Liquid Biopsy Predicts 1st-line Immunotherapy Response Clinical Trial page.

Latest updates to the Liquid Biopsy Predicts 1st-line Immunotherapy Response Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA new revision entry v3.3.2 appears in the Record History, replacing v3.2.0; study status and content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the government funding lapse notice and operating-status details from the page.SummaryDifference0.7%

- Check42 days agoChange DetectedThe record history now shows additional version entries reflecting updates to study status, recruitment, IPD sharing, and amendments to arms/interventions and outcome measures. This indicates ongoing maintenance of the trial record and data sharing status.SummaryDifference0.1%

- Check71 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference12%

- Check78 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

- Check86 days agoChange DetectedAdded newer study-related content and a new section with 2025-09-17/18 identifiers and contacts/locations; removed an older 2024-07-29 entry. Overall, updates reflect refreshed study information.SummaryDifference2%

Stay in the know with updates to Liquid Biopsy Predicts 1st-line Immunotherapy Response Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Liquid Biopsy Predicts 1st-line Immunotherapy Response Clinical Trial page.